Home » Market News » DirectorsTalk Highlights » Batch of Ben and Jerry’s ice cream recalled over undeclared allergens
Allergy therapeutics plc

Batch of Ben and Jerry’s ice cream recalled over undeclared allergens

Consumer goods company Unilever is recalling a batch of Ben and Jerry’s ice cream due to undeclared allergens, the Food Standards Agency (FSA) has reported.

In a statement published on the FSA’s website, the organisation states that the offending ice cream is a batch of Ben and Jerry’s Chunky Monkey Non-Dairy Ice Cream.

An investigation by the FSA discovered that the batch contained almonds, walnuts and soya, none of which were disclosed on the label.

Allergy Therapeutics (LON:AGY) is an international commercial biotechnology group focused on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third-party products from its subsidiaries in nine major European countries and via distribution agreements in an additional fourteen countries. Its broad pipeline of products in clinical development include vaccines for grass, tree and house dust mite, and peanut allergy vaccine in pre-clinical development. Adjuvant systems to boost performance of vaccines outside allergy are also in development.

To read the full news article please click here

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.